Literature DB >> 20674013

Vascular endothelial growth factor (VEGF) and VEGF-receptor expression in placenta of hyperglycemic pregnant women.

L Pietro1, S Daher, M V C Rudge, I M P Calderon, D C Damasceno, Y K Sinzato, C Bandeira, E Bevilacqua.   

Abstract

Hyperglycemia occurs in a variety of conditions such as overt diabetes, gestational diabetes and mild hyperglycemia, all of which are generally defined based on the oral glucose tolerance test and glucose profiles. Whereas diabetes has received considerable attention in recent decades, few studies have examined the mechanisms of mild hyperglycemia and its associated disturbances. Mild gestational hyperglycemia is associated with macrosomia and a high risk of perinatal mortality. Morphologically, the placenta of these women is characterized by an increase in the number of terminal villi and capillaries, presumably as part of a compensatory mechanism to maintain homeostasis at the maternal-fetal interface. In this study, we analised the expression of VEGF and its receptors VEGFR-1 (Flt-1) and VEGFR-2 (KDR) in placentas from mildly hyperglycemic women. This expression was compared with that of normoglycemic women and women with gestational and overt diabetes. Immunohistochemistry revealed strong staining for VEGF and VEGFR-2 in vascular and trophoblastic cells of mildly hyperglycemic women, whereas the staining for VEGFR-1 was discrete and limited to the trophoblast. The pattern of VEGF and VEGF-receptor reactivity in placentas from women with overt diabetes was similar to that of normoglycemic women. In women with gestational diabetes, strong staining for VEGFR-1 was observed in vascular and trophoblastic cells whereas VEGF and VEGFR-2 were detected only in the trophoblast. The expression of these proteins was confirmed by western blotting, which revealed the presence of an additional band of 75 kDa. In the decidual compartment, only extravillous trophoblast reacted with all antibodies. Morphological analysis revealed collagen deposition around large arteries in all groups with altered glycemia. These findings indicate a placental response to altered glycemia that could have important consequences for the fetus. The change in the placental VEGF/VEGFR expression ratio in mild hyperglycemia may favor angiogenesis in placental tissue and could explain the hypercapillarization of villi seen in this gestational disturbance. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674013     DOI: 10.1016/j.placenta.2010.07.003

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  21 in total

1.  Nitric oxide synthase and VEGF expression in full-term placentas of obese women.

Authors:  Eleonora Salvolini; Arianna Vignini; Jacopo Sabbatinelli; Guendalina Lucarini; Veronica Pompei; Davide Sartini; Anna Maria Cester; Andrea Ciavattini; Laura Mazzanti; Monica Emanuelli
Journal:  Histochem Cell Biol       Date:  2019-09-24       Impact factor: 4.304

2.  Influence of maternal hyperglycemia on IL-10 and TNF-α production: the relationship with perinatal outcomes.

Authors:  Jusciele Brogin Moreli; Glilciane Morceli; Ana Karina C De Luca; Claudia G Magalhães; Roberto A A Costa; Débora Cristina Damasceno; Marilza Vieira Cunha Rudge; Iracema Mattos Paranhos Calderon
Journal:  J Clin Immunol       Date:  2011-12-30       Impact factor: 8.317

3.  Study on the correlation and predictive value of serum pregnancy-associated plasma protein A, triglyceride and serum 25-hydroxyvitamin D levels with gestational diabetes mellitus.

Authors:  Zhuo Ren; Dong Zhe; Zhi Li; Xin-Ping Sun; Kai Yang; Li Lin
Journal:  World J Clin Cases       Date:  2020-03-06       Impact factor: 1.337

4.  Gestational diabetes induces chronic hypoxia stress and excessive inflammatory response in murine placenta.

Authors:  Hua-Ping Li; Xuan Chen; Ming-Qing Li
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

5.  Morphological and phenotypic analyses of the human placenta using whole mount immunofluorescence.

Authors:  Meghan E Bushway; Scott A Gerber; Bruce M Fenton; Richard K Miller; Edith M Lord; Shawn P Murphy
Journal:  Biol Reprod       Date:  2014-03-19       Impact factor: 4.285

Review 6.  Role of nitric oxide in placental vascular development and function.

Authors:  B J Krause; M A Hanson; P Casanello
Journal:  Placenta       Date:  2011-07-27       Impact factor: 3.481

Review 7.  Glucose, insulin, and oxygen interplay in placental hypervascularisation in diabetes mellitus.

Authors:  Silvija Cvitic; Gernot Desoye; Ursula Hiden
Journal:  Biomed Res Int       Date:  2014-09-02       Impact factor: 3.411

Review 8.  Could gestational diabetes mellitus be managed through dietary bioactive compounds? Current knowledge and future perspectives.

Authors:  Carmela Santangelo; Alessandra Zicari; Elisabetta Mandosi; Beatrice Scazzocchio; Emanuela Mari; Susanna Morano; Roberta Masella
Journal:  Br J Nutr       Date:  2016-02-16       Impact factor: 3.718

9.  Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies.

Authors:  Qian Meng; Li Shao; Xiucui Luo; Yingping Mu; Wen Xu; Li Gao; Haoqin Xu; Yugui Cui
Journal:  Reprod Biol Endocrinol       Date:  2016-09-20       Impact factor: 5.211

10.  Hyperglycemia induces altered expressions of angiogenesis associated molecules in the trophoblast.

Authors:  Shu-Chun Chang; Wei-Chung Vivian Yang
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.